Characteristics of Nontuberculous Mycobacterial Infections at a Midwestern Tertiary Hospital: A Retrospective Study of 365 Patients
- PMID: 32587875
- PMCID: PMC7305701
- DOI: 10.1093/ofid/ofaa173
Characteristics of Nontuberculous Mycobacterial Infections at a Midwestern Tertiary Hospital: A Retrospective Study of 365 Patients
Abstract
Background: The prevalence of infections due to nontuberculous mycobacteria (NTM) is increasing worldwide, yet little is known about the epidemiology and pathophysiology of these ubiquitous environmental organisms. Pulmonary disease due to Mycobacterium avium complex is most prevalent, but many other NTM species can cause disease in virtually any organ system. As NTM becomes an increasingly common cause of morbidity and mortality, more information is needed about the epidemiology of NTM disease.
Methods: We conducted a retrospective chart review of all patients with cultures that grew NTM at a Midwestern tertiary hospital from 1996 to 2017. Information on demographics, medical history, clinical findings, treatment, and outcome was obtained from medical records of all NTM isolates. American Thoracic Society/Infectious Diseases Society of America criteria were used to define pulmonary NTM infections.
Results: We identified 1064 NTM isolates, 365 of which met criteria for NTM infection. Pulmonary cases predominated (185 of 365; 50.7%), followed by skin/soft tissue (56 of 365; 15.3%), disseminated (40 of 365; 11%), and lymphatic (28 of 365; 7.7%) disease. Mycobacterium avium complex was the most common species (184 of 365; 50.4%). Individuals aged >50 years were most affected (207 of 365; 56.7%). Common comorbidities included structural lung disease (116 of 365; 31.8%), use of immunosuppressive medications (78 of 365; 21.4%), malignancy (59 of 365; 16.2%), and human immunodeficiency virus (42 of 365; 11.5%).
Conclusions: This large cohort provides information on the demographics, risk factors, and disease course of patients with pulmonary and extrapulmonary NTM infections. Most patients had medical comorbidities that resulted in anatomic, genetic, or immunologic risk factors for NTM infection. Further population-based studies and increased disease surveillance are warranted to further characterize NTM infection prevalence and trends.
Keywords: atypical mycobacteria; nontuberculous mycobacteria.
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Figures

Similar articles
-
Nontuberculous Mycobacterial Infections in a French Hospital: A 12-Year Retrospective Study.PLoS One. 2016 Dec 13;11(12):e0168290. doi: 10.1371/journal.pone.0168290. eCollection 2016. PLoS One. 2016. PMID: 27959960 Free PMC article.
-
Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology.Clin Infect Dis. 2009 Dec 15;49(12):e124-9. doi: 10.1086/648443. Clin Infect Dis. 2009. PMID: 19911942
-
Trends from the Last Decade with Nontuberculous Mycobacteria Lung Disease (NTM-LD): Clinicians' Perspectives in Regional Center of Pulmonology in Bydgoszcz, Poland.Pathogens. 2023 Jul 28;12(8):988. doi: 10.3390/pathogens12080988. Pathogens. 2023. PMID: 37623948 Free PMC article.
-
Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8. Respir Med. 2019. PMID: 31128614 Review.
-
Update on the epidemiology of pulmonary nontuberculous mycobacterial infections.Semin Respir Crit Care Med. 2013 Feb;34(1):87-94. doi: 10.1055/s-0033-1333567. Epub 2013 Mar 4. Semin Respir Crit Care Med. 2013. PMID: 23460008 Review.
Cited by
-
Evaluating hemoptysis hospitalizations among patients with bronchiectasis in the United States: a population-based cohort study.BMC Pulm Med. 2021 Dec 1;21(1):392. doi: 10.1186/s12890-021-01762-6. BMC Pulm Med. 2021. PMID: 34852812 Free PMC article.
-
Mycobacterium abscessus alkyl hydroperoxide reductase C promotes cell invasion by binding to tetraspanin CD81.iScience. 2023 Jan 25;26(2):106042. doi: 10.1016/j.isci.2023.106042. eCollection 2023 Feb 17. iScience. 2023. PMID: 36818301 Free PMC article.
-
Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review.Clin Chest Med. 2023 Dec;44(4):675-721. doi: 10.1016/j.ccm.2023.08.012. Epub 2023 Sep 21. Clin Chest Med. 2023. PMID: 37890910 Free PMC article. Review.
-
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine.Infection. 2024 Jun;52(3):737-765. doi: 10.1007/s15010-024-02183-3. Epub 2024 Feb 8. Infection. 2024. PMID: 38329686 Free PMC article. Review.
-
FDG-PET/CT of COVID-19 and Other Lung Infections.Semin Nucl Med. 2022 Jan;52(1):61-70. doi: 10.1053/j.semnuclmed.2021.06.017. Epub 2021 Jun 22. Semin Nucl Med. 2022. PMID: 34246449 Free PMC article. Review.
References
-
- Chung J, Ince D, Ford BA, Wanat KA. Cutaneous infections due to nontuberculous mycobacterium: recognition and management. Am J Clin Dermatol 2018; 19:867–78. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous